V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213737 | 20080131 | 1.66 | 115.6 | Palliative (P) | 2017-05-16 | 2017-05-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101685280 |
| 20213738 | 20080132 | 1.72 | 42.5 | Curative (C) | null | 2019-08-23 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | Y | FLUOROURACIL + MITOMYCIN + RT | 101852020 |
| 20213739 | 20080133 | 1.85 | 102 | null | 2017-09-28 | 2017-10-02 | IMATINIB | N | null | IMATINIB | 100943823 |
| 20213741 | 20080135 | 1.63 | 92.8 | Curative (C) | 2018-03-04 | 2018-03-05 | Trial Unspecified | 1 | N | TRIAL | 101422756 |
| 20213742 | 20080136 | 1.74 | 71.7 | Palliative (P) | 2017-05-03 | 2017-05-09 | HCX (Cape + Cisp + Tras) - Load | 02 | Y | TRIAL | 101220896 |
| 20213745 | 20080137 | 1.51 | 46 | Adjuvant (A) | 2018-05-06 | 2018-05-13 | IMATINIB | N | N | IMATINIB | 100993744 |
| 20213746 | 20080138 | 1.7 | 46.8 | Palliative (P) | 2018-08-20 | 2018-08-24 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100775238 |
| 20213747 | 20080139 | 1.8 | 128.5 | null | 2017-09-23 | 2017-09-23 | Trial Unspecified | 1 | null | TRIAL | 100050721 |
| 20213748 | 20080140 | 1.61 | 78 | Curative (C) | 2017-02-25 | 2017-03-06 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 101130980 |
| 20213749 | 20080141 | 1.84 | 76.4 | Palliative (P) | 2019-02-09 | 2019-02-12 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101810424 |
| 20213750 | 20080142 | null | null | Palliative (P) | 2018-04-07 | 2018-04-07 | Imatinib 400mg | 02 | N | IMATINIB | 100043465 |
| 20213751 | 20080143 | 1.74 | 72 | Curative (C) | null | 2019-03-03 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101857930 |
| 20213752 | 20080144 | 1.51 | 63.3 | Curative (C) | 2019-10-10 | 2019-10-22 | FLUOROURACIL + MITOMYCIN + RT | null | Y | FLUOROURACIL + MITOMYCIN + RT | 100894120 |
| 20213753 | 20080145 | 0 | 76.7 | Neo-adjuvant (N) | 2019-10-31 | 2019-11-06 | Imatinib 400mg | 02 | N | IMATINIB | 100620087 |
| 20213754 | 20080146 | 1.7 | 75.3 | Palliative (P) | 2017-08-30 | 2017-08-30 | Trial Unspecified | 02 | N | TRIAL | 100437911 |
| 20213755 | 20080147 | 1.57 | 80 | Palliative (P) | 2018-04-27 | 2018-05-23 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100073544 |
| 20213756 | 20080148 | 1.75 | null | Curative (C) | 2019-05-16 | 2019-06-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100578650 |
| 20213757 | 20080149 | 1.7 | 83 | Palliative (P) | 2017-06-01 | 2017-06-15 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101161784 |
| 20213758 | 20080150 | 0 | null | Palliative (P) | 2017-03-04 | 2017-03-06 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | LANREOTIDE | 101145204 |
| 20213760 | 20080152 | 1.57 | 96.1 | null | 2016-03-15 | 2016-03-15 | Imatinib 400mg | 02 | null | IMATINIB | 101357660 |
| 20213761 | 20080153 | 1.81 | 68.95 | Adjuvant (A) | 2016-06-11 | 2016-07-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100948937 |
| 20213763 | 20080154 | 1.73 | 72 | Curative (C) | null | 2018-08-06 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101550487 |
| 20213766 | 20080155 | 1.68 | 0 | Palliative (P) | 2020-05-06 | 2020-06-09 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100201202 |
| 20213767 | 20080156 | 1.46 | 115.6 | Curative (C) | 2015-10-05 | 2015-10-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100552850 |
| 20213769 | 20080158 | 1.84 | 70.7 | Palliative (P) | 2017-06-05 | 2017-06-11 | Trial Unspecified | N | N | TRIAL | 100228001 |
| 20213770 | 20080159 | 1.73 | 76.5 | null | 2019-08-08 | 2019-08-08 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | LANREOTIDE | 100695308 |
| 20213772 | 20080160 | 1.7 | null | Curative (C) | 2017-07-26 | 2017-08-04 | HCX (Cape + Cisp + Tras) - Main | 02 | N | IMATINIB | 101779967 |
| 20213774 | 20080161 | 1.7 | null | Curative (C) | 2018-10-09 | 2018-10-13 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 100904765 |
| 20213775 | 20080162 | 1.76 | 81.3 | Adjuvant (A) | 2017-07-29 | 2017-07-31 | IMATINIB | 02 | N | IMATINIB | 101265102 |
| 20213779 | 20080163 | 1.69 | null | Curative (C) | 2016-08-30 | 2016-10-05 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101689906 |
| 20213780 | 20080164 | 1.71 | 47 | Palliative (P) | 2018-05-30 | 2018-06-06 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101600647 |
| 20213781 | 20080165 | null | 0 | Palliative (P) | 2019-07-15 | 2019-07-15 | LANREOTIDE | 02 | N | LANREOTIDE | 100189378 |
| 20213782 | 20080166 | 0 | 58.1 | Palliative (P) | 2017-10-12 | 2017-10-31 | HCX | 02 | N | IMATINIB | 101348188 |
| 20213783 | 20080167 | null | null | null | 2018-10-18 | 2018-10-28 | Cape+Cisplatin+Trastuzumab Load | 02 | null | IMATINIB | 101190746 |
| 20213785 | 20080168 | 1.83 | 94.5 | Palliative (P) | null | 2018-07-22 | HCX (Cape + Cisp + Tras) - Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101160806 |
| 20213786 | 20080169 | 1.81 | 78.4 | Palliative (P) | 2018-11-26 | 2018-12-10 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101828054 |
| 20213787 | 20080170 | 1.66 | 46 | Palliative (P) | 2018-06-03 | 2018-06-23 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100733529 |
| 20213791 | 20080173 | 1.55 | 64 | Palliative (P) | 2017-08-21 | 2017-08-27 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100643711 |
| 20213792 | 20080174 | 1.6 | 93.2 | null | 2016-10-15 | 2016-10-29 | HCX (Cape + Cisp + Tras) - Load | 02 | null | LANREOTIDE | 101371701 |
| 20213793 | 20080175 | 1.66 | 66.75 | null | 2017-04-25 | 2017-05-25 | LANREOTIDE | 02 | null | LANREOTIDE | 101341443 |
| 20213794 | 20080176 | 1.67 | 61 | Palliative (P) | 2017-06-25 | 2017-07-08 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100369178 |
| 20213795 | 20080177 | 1.6 | 0 | Disease modification (D) | 2017-11-21 | 2017-12-12 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100584143 |
| 20213796 | 20080178 | 1.71 | 66.9 | null | 2016-08-05 | 2016-08-08 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101041196 |
| 20213797 | 20080179 | 1.63 | 75.6 | null | 2017-12-29 | 2017-12-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | FLUOROURACIL + MITOMYCIN + RT | 101831402 |
| 20213798 | 20080180 | 1.55 | 76.7 | 03 | null | 2019-08-16 | LANREOTIDE | 02 | N | LANREOTIDE | 100099427 |
| 20213800 | 20080182 | 1.74 | 65.3 | Curative (C) | 2019-08-13 | 2019-08-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101226477 |
| 20213801 | 20080183 | 1.59 | 68.7 | null | 2017-11-18 | 2017-11-23 | HCX (Cape + Cisp + Tras) - Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100269055 |
| 20213802 | 20080184 | 1.67 | 59.9 | null | 2021-05-05 | 2021-05-14 | LANREOTIDE | 02 | N | LANREOTIDE | 100049754 |
| 20213803 | 20080185 | 1.57 | 87 | Curative (C) | 2017-08-19 | 2017-08-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100426993 |
| 20213804 | 20080186 | null | 76 | Disease modification (D) | 2017-08-31 | 2017-09-21 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | FLUOROURACIL + MITOMYCIN + RT | 100374180 |